Seeking Alpha

Perrigo (PRGO -0.3%) has received FDA approval to market polacrilex, its OTC mini nicotine...

Perrigo (PRGO -0.3%) has received FDA approval to market polacrilex, its OTC mini nicotine lozenges. The mint flavored mini lozenge will be marketed under retailer and wholesalers'store, or own brand labels, and is comparable to GlaxoSmithKline's (GSK -0.3%) Nicorette Mini Lozenge. PRGO says is lozenge is the first product approved that will target the individual store brand market.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs